Mercer Global Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.11M Buy
90,472
+26,403
+41% +$1.54M 0.01% 752
2025
Q4
$3.81M Buy
64,069
+910
+1% +$49.5K 0.01% 818
2025
Q3
$3.42M Buy
63,159
+29,624
+88% +$1.69M 0.01% 804
2025
Q2
$1.84M Buy
33,535
+3,791
+13% +$223K ﹤0.01% 920
2025
Q1
$2.1M Buy
29,744
+11,641
+64% +$783K ﹤0.01% 827
2024
Q4
$1.19M Buy
18,103
+9,915
+121% +$664K ﹤0.01% 1024
2024
Q3
$574K Sell
8,188
-3,980
-33% -$333K ﹤0.01% 1263
2024
Q2
$1.01M Sell
12,168
-104
-0.8% -$8.66K ﹤0.01% 960
2024
Q1
$1.07M Sell
12,272
-263
-2% -$23.5K ﹤0.01% 935
2023
Q4
$1.21M Sell
12,535
-180
-1% -$15.9K ﹤0.01% 901
2023
Q3
$1.13M Sell
12,715
-2,839
-18% -$253K ﹤0.01% 898
2023
Q2
$1.35M Sell
15,554
-60
-0.4% -$5.65K 0.01% 843
2023
Q1
$1.52M Sell
15,614
-679
-4% -$70.4K 0.01% 762
2022
Q4
$1.69M Sell
16,293
-1,594
-9% -$150K 0.01% 724
2022
Q3
$1.52M Sell
17,887
-1,486
-8% -$132K 0.01% 708
2022
Q2
$1.6M Buy
19,373
+16
+0.1% +$1.27K 0.01% 668
2022
Q1
$1.49M Sell
19,357
-7
-0% -$586 0.01% 749
2021
Q4
$1.71M Buy
19,364
+615
+3% +$50.7K 0.01% 678
2021
Q3
$1.45M Sell
18,749
-5,375
-22% -$424K 0.01% 734
2021
Q2
$2.01M Sell
24,124
-61
-0.3% -$4.84K 0.02% 567
2021
Q1
$1.83M Sell
24,185
-2,380
-9% -$194K 0.02% 551
2020
Q4
$2.33M Buy
26,565
+314
+1% +$24.9K 0.03% 390
2020
Q3
$2M Buy
26,251
+23,384
+816% +$2.37M 0.03% 382
2020
Q2
$354K Buy
2,867
+34
+1% +$3.38K 0.01% 796
2020
Q1
$239K Buy
2,833
+14
+0.5% +$1.21K 0.01% 887
2019
Q4
$238K Buy
+2,819
New +$213K ﹤0.01% 1008
2019
Q3
Sell
-2,725
Closed -$233K 1134
2019
Q2
$233K Buy
2,725
+84
+3% +$7.19K 0.01% 982
2019
Q1
$235K Buy
+2,641
New +$245K 0.01% 928

Other funds holding BMRN